Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Peptides And Amino Acids > Powder N-Acetyl-L-Tryptophan CAS 1218-34-4 Used As A Competitive Inhibitor

Powder N-Acetyl-L-Tryptophan CAS 1218-34-4 Used As A Competitive Inhibitor

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1218-34-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:

N-Acetyl-L-Tryptophan CAS 1218-34-4

,

Powder N-Acetyl-L-Tryptophan

CAS NO::
1218-34-4
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C13H14N2O3
Molecular Weight::
246.262
EINECS NO::
214-935-9
MDL NO::
MFCD00065976
CAS NO::
1218-34-4
Appearance::
White To Off-white Crystalline Powder
Molecular Formula::
C13H14N2O3
Molecular Weight::
246.262
EINECS NO::
214-935-9
MDL NO::
MFCD00065976
Powder N-Acetyl-L-Tryptophan CAS 1218-34-4 Used As A Competitive Inhibitor

Product Description:

Product Name: N-Acetyl-L-Tryptophan CAS NO:1218-34-4

 

Synonyms:

(2S)-2-acetamido-3-(1 H-indol-3-yl)propanoic acid;

N-Acetyl-Trp-OH;

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline powder

Assay :≥99.0%

Density:1.33g/cm3

Boiling Point:586.6℃ at 760 mmHg

Flash Point:308.6℃

Melting Point:190℃

 

 

N-Acetyl-L-Tryptophan, is a derivative of L-Tryptophan, that can be used as competitive inhibitor to identify and characterize tryptophanases. It can also be used as an NK1 tachykinin receptor antagonist, that may help to develop a novel therapeutic intervention for the treatment of reperfusion injury in acute ischemic stroke.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.